Laurion Capital Management’s Cardiff Oncology CRDF Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.29M	Hold	2,646,738	–	–	0.19%	146
2025 Q4	$7.44M	Buy	2,646,738 +180,866	+7%	+$420K	0.28%	65
2025 Q3	$5.08M	Buy	2,465,872 +668,590	+37%	+$1.85M	0.09%	128
2025 Q2	$5.66M	Buy	1,797,282 +881,068	+96%	+$2.69M	0.1%	130
2025 Q1	$2.88M	Buy	916,214 +339,290	+59%	+$1.34M	0.07%	132
2024 Q4	$2.5M	Buy	+576,924	New	+$1.8M	0.05%	178
2024 Q2	–	Sell	-928,717	Closed	-$4.96M	–	598
2024 Q1	$4.96M	Buy	928,717 +206,617	+29%	+$549K	0.04%	256
2023 Q4	$1.07M	Hold	722,100	–	–	0.01%	336
2023 Q3	$1M	Hold	722,100	–	–	0.01%	368
2023 Q2	$1.06M	Hold	722,100	–	–	0.01%	363
2023 Q1	$1.19M	Hold	722,100	–	–	0.01%	297
2022 Q4	$1.01M	Hold	722,100	–	–	﹤0.01%	335
2022 Q3	$1.11M	Hold	722,100	–	–	0.01%	364
2022 Q2	$1.59M	Buy	+722,100	New	+$1.21M	0.02%	247